Discrepancies between plasma procalcitonin and C-reactive protein levels are common in acute illness

Lauri Ivaska1, Varpu Elenius1, Ilkka Mononen2,3

  • 1Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.

Insights

Discrepancies between procalcitonin (PCT) and C-reactive protein (CRP) occurred in 29% of hospitalized children. PCT may be more advantageous than CRP in diagnosing bacteremia, even when bacterial infection is absent.

Area of Science:

  • Biochemistry
  • Clinical Medicine
  • Pediatrics

Background:

  • Procalcitonin (PCT) and C-reactive protein (CRP) are key biomarkers for bacterial infections.
  • These biomarkers possess distinct clinical utility in infection diagnosis.
  • Understanding discrepancies between PCT and CRP is crucial for accurate patient management.

Purpose of the Study:

  • To investigate the incidence of discrepancies between plasma PCT and CRP levels in hospitalized children.
  • To analyze the clinical significance and implications of these biomarker level differences.

Main Methods:

  • Retrospective analysis of 635 simultaneous PCT and CRP measurements from a single center.
  • Comparison of clinical characteristics, microbiological findings, and diagnoses between groups with discordant PCT and CRP levels.

Main Results:

  • Discrepancies between PCT and CRP were observed in 29% of the cases studied.
  • Elevated PCT with low CRP was linked to hypoxia, hemodynamic stress, and bacteremia.
  • Elevated CRP with low PCT correlated with focal bacterial infections, inflammatory conditions, and postoperative settings.
  • Diabetic ketoacidosis showed a strong association with markedly elevated PCT levels.

Conclusions:

  • Discrepancies in PCT and CRP levels are common in acutely ill children (29%).
  • While both biomarkers can elevate without bacterial infection, PCT shows potential advantages in diagnosing bacteremia.
  • PCT may provide superior diagnostic value compared to CRP in specific pediatric critical care scenarios.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
742
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
527
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
421
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K